Heterogeneous spectrum of neuropathies in Waldenström's macroglobulinemia: A diagnostic strategy to optimize their management

Journal of the Peripheral Nervous System

Volumn 17, Issue 1, 2012, Pages 90-101

  Viala, Karine ^a   Stojkovic, Tanya ^a   Doncker, Anne Violaine ^a   Maisonobe, Thierry ^a   Lenglet, Timotheé ^a   Bruneteau, Gaëlle ^a   Musset, Lucile ^a   Neil, Jean ^a   Leǵer, Jean Marc ^a   Leblond, Veŕonique ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

Amyloid neuropathy; CIDP; Cryoglobulinemia; Peripheral neuropathy; Waldenstr m's macroglobulinemia

Indexed keywords

GANGLIOSIDE ANTIBODY;

ADULT; AGED; AMYLOID NEUROPATHY; ARTICLE; CLINICAL ARTICLE; CRYOGLOBULINEMIA; DIAGNOSTIC PROCEDURE; ELECTROMYOGRAM; FEMALE; GIANT AXONAL NEUROPATHY; HUMAN; MALE; MOTOR NEUROPATHY; NEUROPATHY; POLYRADICULONEUROPATHY; PRIORITY JOURNAL; TREATMENT PLANNING; WALDENSTROEM MACROGLOBULINEMIA;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM DISEASES; RETROSPECTIVE STUDIES; WALDENSTROM MACROGLOBULINEMIA;

EID: 84859400349     PISSN: 10859489     EISSN: 15298027     Source Type: Journal    
DOI: 10.1111/j.1529-8027.2012.00376.x     Document Type: Article

References (38)

1. Baehring JM, Hochberg EP, Raje N, Ulrickson M, Hochberg FH (2008). Neurological manifestations of Waldenstrom macroglobulinemia. Nat Clin Pract Neurol 4:547-556.
2. Bajada S, Mastaglia FL, Fisher A (1980). Amyloid neuropathy and tremor in Waldenstrom's macroglobulinemia. Arch Neurol 37:240-242. (Pubitemid 10156370)
3. Baldini L, Nobile-Orazio E, Guffanti A, Barbieri S, Carpo M, Cro L, Cesana B, Damilano I, Maiolo AT (1994). Peripheral neuropathy in IgM monoclonal gammopathy and Waldenstrom's macroglobulinemia: a frequent complication in elderly males with low MAG-reactive serum monoclonal component. Am J Hematol 45:25-31. (Pubitemid 23362871)
4. Caudie C, Kaygisiz F, Jaquet P, Petiot P, Gonnaud PM, Antoine JC, Vial C (2006). Diagnostic value of autoantibodies to MAG by ELISA Buhlmann in 117 immune-mediated peripheral neuropathies associated with monoclonal IgM to SGPG/SGLPG. Ann Biol Clin (Paris) 64:353-359. (Pubitemid 44212921)
5. Dellagi K, Dupouey P, Brouet JC, Billecocq A, Gomez D, Clauvel JP, Seligmann M (1983). Waldenstrom's macroglobulinemia and peripheral neuropathy: a clinical and immunologic study of 25 patients. Blood 62:280-285. (Pubitemid 13036074)
6. Dimopoulos MA, Panayiotidis P, Moulopoulos LA, Sfikakis P, DalakasM(2000).Waldenstrom's macroglobulinemia: clinical features, complications, and management. J Clin Oncol 18:214-226. (Pubitemid 30036355)
7. Freddo L, Hays AP, Sherman WH, Latov N (1985). Axonal neuropathy in a patient with IgM M-protein reactive with nerve endoneurium. Neurology 35:1321-1325. (Pubitemid 15021594)
8. Gertz MA, Merlini G, Treon SP (2004). Amyloidosis and Waldenstrom's macroglobulinemia. Hematology (Am Soc Hematol Educ Program) (1):257-282.
9. Gordon PH, Rowland LP, Younger DS, Sherman WH, Hays AP, Louis ED, Lange DJ, Trojaborg W, Lovelace RE, Murphy PL, Latov N (1997). Lymphoproliferative disorders and motor neuron disease: an update. Neurology 48:1671-1678.
10. Itzykson R, Le Garff-TavernierM, Katsahian S, Diemert MC, Musset L, Leblond V (2008). Serum-free light chain elevation is associated with a shorter time to treatment in Waldenstrom's macroglobulinemia. Haematologica 93:793-794. (Pubitemid 351669328)
11. Johnson PC, Rolak LA, Hamilton RH, Laguna JF (1979). Paraneoplastic vasculitis of nerve: a remote effect of cancer. Ann Neurol 5:437-444. (Pubitemid 9150135)
12. Joint Task Force of the EFNS and the PNS (2010). European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-first revision. J Peripher Nerv Syst 15:1-9.
13. Kaku DA, England JD, Sumner AJ (1994). Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside. Brain 117:941-947. (Pubitemid 24350530)
14. Klein CJ, Moon JS, Mauermann ML, Zeldenrust SR, Wu Y, Dispenzieri A, Dyck PJ (2011). The neuropathies of Waldenstrom's macroglobulinemia (WM) and IgM-MGUS. Can J Neurol Sci 38:289-295.
15. Kuijf ML, Eurelings M, Tio-Gillen AP, van Doorn PA, van den Berg LH, Hooijkaas H, Stork J, Notermans NC, Jacobs BC (2009). Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy. Neurology 73:688-695.
16. Lamarca J, Casquero P, Pou A (1987). Mononeuritis multiplex in Waldenstrom's macroglobulinemia. Ann Neurol 22:268-272. (Pubitemid 17131158)
17. Larue S, Bombelli F, Viala K, Neil J, Maisonobe T, Bouche P, Musset L, Fournier E, Leger JM (2011). Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases. Eur J Neurol 18:899-905.
18. Levine T, Pestronk A, Florence J, Al-Lozi MT, Lopate G, Miller T, Ramneantu I, Waheed W, Stambuk M, Stone MJ, Choksi R (2006). Peripheral neuropathies inWaldenstrom's macroglobulinaemia. J Neurol Neurosurg Psychiatry 77:224-228.
19. Mauermann ML, Ryan ML, Moon JS, Klein CJ (2007). Case of mononeuritis multiplex onset with rituximab therapy for Waldenstrom's macroglobulinemia. J Neurol Sci 260:240-243. (Pubitemid 47212195)
20. Meier C, Vandevelde M, Steck A, Zurbriggen A (1984). Demyelinating polyneuropathy associated with monoclonal IgMparaproteinaemia. Histological, ultrastructural and immunocytochemical studies. J Neurol Sci 63:353-367. (Pubitemid 14136442)
21. Musset L, Diemert MC, Taibi F, Thi Huong Du L, Cacoub P, Leger JM, Boissy G, Gaillard O, Galli J (1992). Characterization of cryoglobulins by immunoblotting. Clin Chem 38:798-802.
22. Niermeijer JM, Fischer K, Eurelings M, Franssen H, Wokke JH, Notermans NC (2010). Prognosis of polyneuropathy due to IgM monoclonal gammopathy: a prospective cohort study. Neurology 74:406-412.
23. Nobile-Orazio E (2004). IgM paraproteinaemic neuropathies. Curr Opin Neurol 17:599-605.
24. Nobile-Orazio E (2008). What's new in multifocal motor neuropathy in 2007-2008? J Peripher Nerv Syst 13:261-263.
25. Nobile-Orazio E, Marmiroli P, Baldini L, Spagnol G, Barbieri S, Moggio M, Polli N, Polli E, Scarlato G (1987). Peripheral neuropathy in macroglobulinemia: incidence and antigen-specificity of M proteins. Neurology 37:1506-1514. (Pubitemid 17132332)
26. Noguchi M, Mori K, Yamazaki S, Suda K, Sato N, Oshimi K (2003). Multifocal motor neuropathy caused by a B-cell lymphoma producing a monoclonal IgM autoantibody against peripheral nerve myelin glycolipids GM1 and GD1b. Br J Haematol 123:600-605. (Pubitemid 37468055)
27. Ortiz N, Rosa R, Gallardo E, Illa I, Tomas J, Aubry J, Sabater M, Santafe M (2001). IgM monoclonal antibody against terminal moiety of GM2, GalNAc-GD1a and GalNAc-GM1b from a pure motor chronic demyelinating polyneuropathy patient: effects on neurotransmitter release. J Neuroimmunol 119:114-123. (Pubitemid 32781736)
28. Owen RG, Treon SP, Al-Katib A, Fonseca R, Greipp PR, McMaster ML, Morra E, Pangalis GA, San Miguel JF, Branagan AR, Dimopoulos MA (2003). Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol 30:110-115.
29. Pestronk A, Choksi R, Logigian E, Al-Lozi MT (2003). Sensory neuropathy with monoclonal IgM binding to a trisulfated heparin disaccharide. Muscle Nerve 27:188-195. (Pubitemid 36169330)
30. Quattrini A, Nemni R, Fazio R, Iannaccone S, Lorenzetti I, Grassi F, Canal N (1991). Axonal neuropathy in a patient with monoclonal IgM kappa reactive with Schmidt-Lantermann incisures. J Neuroimmunol 33:73-79.
31. Rowland LP, Defendini R, Sherman W, Hirano A, Olarte MR, Latov N, Lovelace RE, Inoue K, Osserman EF (1982). Macroglobulinemia with peripheral neuropathy simulating motor neuron disease. Ann Neurol 11:532-536. (Pubitemid 12158816)
32. Rowland LP, Sherman WL, Hays AP, Lange DJ, Latov N, Trojaborg W, Younger DS (1995). Autopsy-proven amyotrophic lateral sclerosis,Waldenstrom's macroglobulinemia, and antibodies to sulfated glucuronic acid paragloboside. Neurology 45:827-829.
33. Sherman WH, Latov N, Hays AP, Takatsu M, Nemni R, Galassi G, Osserman EF (1983). Monoclonal IgM kappa antibody precipitating with chondroitin sulfate C from patients with axonal polyneuropathy and epidermolysis. Neurology 33:192-201. (Pubitemid 13137361)
34. Van den Bergh PY, Hadden RD, Bouche P, Cornblath DR, Hahn A, Illa I, Koski CL, Léger JM, Nobile-Orazio E, Pollard J, Sommer C, van Doorn PA, van Schaik IN; European Federation of Neurological Societies; Peripheral Nerve Society (2010). European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision. Eur J Neurol 17:356-363
35. Viala K, Behin A, Maisonobe T, Leger JM, Stojkovic T, Davi F, Leblond V, Bouche P (2007). Neuropathy in lymphoma: a relationship between the pattern of neuropathy, type of lymphoma and prognosis? J Neurol Neurosurg Psychiatry.
36. Viala K, Renie L, Maisonobe T, Behin A, Neil J, Leger JM, Bouche P (2004). Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome. Brain 127:2010-2017.
37. Vital C, Deminiere C, Bourgouin B, Lagueny A, David B, Loiseau P (1985). Waldenstrom's macroglobulinemia and peripheral neuropathy: deposition ofM-component and kappa light chain in the endoneurium. Neurology 35:603-606. (Pubitemid 15085094)
38. Vital C, Vallat JM, Deminiere C, Loubet A, Leboutet MJ (1982). Peripheral nerve damage during multiple myeloma andWaldenstrom's macroglobulinemia: an ultrastructural and immunopathologic study. Cancer 50:1491-1497. (Pubitemid 12034542)